ISNTD d3 2021
ISNTD d³ 2021 addresses the current gaps and collaboration opportunities across tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities.
This year, against the backdrop of the recently launched WHO NTD Roadmap and the shock of the COVID19 pandemic, ISNTD d³ will focus on the shifts, gaps and future needs of drug discovery, treatments and diagnostics in context of global health as well as broader challenges.
Presentations & panel discussions will run on both days, and partnership meetings can be arranged throughout the day.
Please contact krafiq [at] isntd [dot] org for further details including speaking & attending and to become a conference sponsor.
Programme
DRUG DISCOVERY & DEVELOPMENT - ISNTD d3 2021: DAY 1, 24 FEB 2021
9.00-10.00 UTC - Rethinking financial incentives for drugs and diagnostics for Neglected Tropical Diseases
Andrew Jack (Financial Times) - Panel chair
Dr Hayato Urabe (Senior Director, Investment Strategy, Portfolio Development & Innovations, GHIT Fund)
Dr Olawale Ajose (Head of Access, Neglected Tropical Diseases, DNDi)
Dr Beatrice Greco (Head of R&D and Access, Global Health Institute, Merck)
Margo Warren (Government Engagement & Policy Manager, Access to Medicine Foundation)
10.15-11.45 UTC - Putting access at the centre of future drug development
Margo Warren (Government Engagement & Policy Manager, Access to Medicine Foundation)
Dr Isaac Chikwanha (Senior Director: Investment Strategy, Access & Delivery, GHIT Fund)
Dr Olawale Ajose (Head of Access, Neglected Tropical Diseases, DNDi)
The Leprosy Mission England & Wales patient voices
12.00-13.00 UTC - Focus: snakebite & snakebite envenoming
- The reasons and consequences of snakebite victims often failing to access effective healthcare
- The gaps and consequences of antivenom treatment of snakebite victims
- Research to help WHO meet its objective of halving snakebite mortality and morbidity by 2030
13.15-14.45 UTC - Drug repurposing for neglected tropical diseases & COVID19
Dr Nathalie Strub-Wourgaft (Director of Neglected Tropical Diseases, DNDi)
Heather Stone (Health Science Policy Analyst, US Food & Drug Administration)
Ivermectin and COVID: what's going on?
Dr Carlos Chaccour (BOHEMIA Chief Scientific Officer, ISGlobal)
Drug repurposing for controlling vectorial transmission of Neglected Tropical Diseases
Dr Alvaro Acosta-Serrano (Liverpool School of Tropical Medicine) & Dr Laith Yakob (London School of Hygiene & Tropical Medicine)
When secretomes meet anthelmintics: lessons for therapeutic interventions
Dr Lucienne Tritten (University of Zurich)
15.00-16.30 UTC - Focus: leishmaniasis
Visceral leishmaniasis: the discovery & clinical landscape
Prof Maria Paola Costi (Drug Discovery and Biotechnology Lab, University of Modena and Reggio Emilia, UNIMORE)
Dr Fabiana Alves (Head of Visceral Leishmaniasis Clinical Programme, DNDi)
Cutaneous leishmaniasis: from bench to cure
Dr Byron Arana (Head of Cutaneous Leishmaniasis, DNDi)
Topical treatments for cutaneous leishmaniasis
Prof Dolores Carrer (Biophysics and Nanotechnology Lab, INIMEC-CONICET-UNC, Argentina)
Biophysical characterization and integrated MD simulation studies of Trypanothione Reductase in Leishmania major
Anurag Kumar (Computational & Systems Biology Lab, National Centre For Cell Science, Pune, Maharashtra, India)
DIAGNOSTICS FOR NEGLECTED TROPICAL DISEASES - ISNTD d3 2021: DAY 2, 25 FEB 2021
9.15-11.00 UTC - Essential diagnostics for neglected tropical diseases: from technology to access, for disease elimination
Launch of the World Health Organisation's third Essential Diagnostics List
Dr Francis Moussy (Leader, Diagnostics & other Health Technologies and Essential Diagnostics List Secretariat, World Health Organisation)
Access to visceral leishmaniasis diagnostics and impact towards attaining the elimination targets in Kenya
Dr Dziedzom Komi de Souza (Senior Scientific Officer, NTD programme, Foundation for Innovative New Diagnostics, FIND)
Focus: schistosomiasis
Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection; a modelling study
Dr Jessica Clark (University of Glasgow)
Kato-Katz and POC-CCA to determine the efficacy of treatments for Schistosoma mansoni infection in school-aged children in Côte d'Ivoire
Dr Dziedzom Komi de Souza (Senior Scientific Officer, NTD programme, Foundation for Innovative New Diagnostics, FIND)
11.15-12.30 UTC - Diagnostics innovation for tropical diseases
CRISPR-Cas9-based Point-of-care (PoC) diagnostics for infectious diseases in resource-limited settings
Dr. Mitasha Bharadwaj (Delft University of Technology, Kavli Institute of Nanoscience Delft, Department of Bionanoscience)
LAMP for Mycobacterium bovis & neglected disease diagnostics
Dr Thoko Flav Kapalamula (Hokkaido University, Japan)
DAT, ELISA & RDT for visceral leishmaniasis in Ethiopia
Dr Johan van Griensven (ITM Antwerp)
A lab-on-chip system to detect malaria
Kenny Malpartida Cardenas (Department of Electrical and Electronic Engineering, Imperial College London)
12.30-14.00 UTC - Diagnostics gaps for vector-borne diseases & the challenges of febrile illnesses
Diagnostic gaps and challenges for primary healthcare delivery in resource-poor settings
Dr Prudence Hamade (Malaria Consortium)
Digital diagnostics for Africa: more than filling the gap
Dr Aubrey Cunnington (Department of Infectious Disease, Imperial College London)
Multiplex panels for the accurate diagnosis of nonmalarial febrile illnesses
Dr Sam Duodu (West African Centre for Cell Biology of Infectious Pathogens, University of Ghana)
Novel biomarkers to distinguish between causes of febrile illness
Dr Myrsini Kaforou (Department of Infectious Disease, Imperial College London)
14.15-15.45 UTC - Diagnostics beyond diagnosis: evaluation, surveillance & monitoring
Rethinking neglected tropical disease diagnostics to achieve elimination
Katie Gass (Director of Research, The Task Force for Global Health, Neglected Tropical Diseases Support Center, NTD-SC)
Why we need the next generation of point of care tests
Dr Francis Krampa (West African Centre for Cell Biology of Infectious Pathogens, University of Ghana)
Genomic-informed pathogen surveillance in Africa: opportunities and challenges
Dr Seth Inzaule (Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia)
Value and application of data from digital diagnostics
Darlington Akogo (Director of minoHealth AI Labs, Ghana)
The need for better diagnostics for environmental pathogen detection
Dr Anthony Sifuna (Masinde Muliro University of Science and Technology, Kenya)